BioRem Inc. (CVE:BRM – Free Report) – Cormark cut their FY2025 earnings per share (EPS) estimates for BioRem in a research note issued to investors on Tuesday, April 22nd. Cormark analyst N. Boychuk now forecasts that the company will post earnings of $0.21 per share for the year, down from their previous estimate of $0.22. Cormark also issued estimates for BioRem’s FY2026 earnings at $0.27 EPS.
BioRem Stock Down 0.5 %
Shares of CVE BRM opened at C$1.94 on Wednesday. The company’s fifty day simple moving average is C$2.36 and its 200 day simple moving average is C$2.70. BioRem has a 12-month low of C$1.84 and a 12-month high of C$3.45. The firm has a market cap of C$31.81 million, a PE ratio of 5.99 and a beta of 0.85. The company has a quick ratio of 1.08, a current ratio of 1.91 and a debt-to-equity ratio of 37.47.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
See Also
- Five stocks we like better than BioRem
- Why Are These Companies Considered Blue Chips?
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- What is a Bond Market Holiday? How to Invest and Trade
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- How is Compound Interest Calculated?
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
